Initial Results – BURST-AF Clinical Trial
Coherent Sine Burst Electroporation. Versatile. Safe. Efficient. Backed by published results from BURST-AF, NCT05572047.
Coherent Sine Burst (CSE) Electroporation System Pilot Study in Patients with Atrial Fibrillation (BURST–AF)
ClinicalTrials.gov ID NCT05572047
BURST–AF is a prospective, single-arm, multi-national, non-randomized study designed to provide clinical data to support the use of the Argá Medtech System in the ablation of atrial fibrillation.
Coming soon:
US IDE trial in paroxysmal and persistent atrial fibrillation. If interested in participating in the US trial, please contact Steven McQuillan.
Copyright © 2024 Argá Medtech SA - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.